1190 related articles for article (PubMed ID: 34248968)
1. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
Front Immunol; 2021; 12():683800. PubMed ID: 34248968
[TBL] [Abstract][Full Text] [Related]
2. Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.
Al-Qahtani AA; Lyroni K; Aznaourova M; Tseliou M; Al-Anazi MR; Al-Ahdal MN; Alkahtani S; Sourvinos G; Tsatsanis C
Oncotarget; 2017 Feb; 8(6):9053-9066. PubMed ID: 28118607
[TBL] [Abstract][Full Text] [Related]
3. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
5. Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling.
Keewan E; Beg S; Naser SA
Front Immunol; 2021; 12():641295. PubMed ID: 34025650
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming.
Umar S; Palasiewicz K; Meyer A; Kumar P; Prabhakar BS; Volin MV; Rahat R; Al-Awqati M; Chang HJ; Zomorrodi RK; Rehman J; Shahrara S
Cell Mol Life Sci; 2022 May; 79(6):301. PubMed ID: 35588018
[TBL] [Abstract][Full Text] [Related]
7. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K
J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril).
Barhoumi T; Alghanem B; Shaibah H; Mansour FA; Alamri HS; Akiel MA; Alroqi F; Boudjelal M
Front Immunol; 2021; 12():728896. PubMed ID: 34616396
[TBL] [Abstract][Full Text] [Related]
9. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
[TBL] [Abstract][Full Text] [Related]
10. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.
Satta S; Meng Z; Hernandez R; Cavallero S; Zhou T; Hsiai TK; Zhou C
Theranostics; 2022; 12(6):2639-2657. PubMed ID: 35401811
[No Abstract] [Full Text] [Related]
11. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
[TBL] [Abstract][Full Text] [Related]
12. TRPV2-spike protein interaction mediates the entry of SARS-CoV-2 into macrophages in febrile conditions.
Xu J; Yang Y; Hou Z; Jia H; Wang Y
Theranostics; 2021; 11(15):7379-7390. PubMed ID: 34158856
[TBL] [Abstract][Full Text] [Related]
13. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
Ramasamy S; Subbian S
Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
[TBL] [Abstract][Full Text] [Related]
14. Macrophage subsets exhibit distinct E. coli-LPS tolerisable cytokines associated with the negative regulators, IRAK-M and Tollip.
Al-Shaghdali K; Durante B; Hayward C; Beal J; Foey A
PLoS One; 2019; 14(5):e0214681. PubMed ID: 31120887
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Inflammation by IRAK-M Pathway Can Be Associated with nAchRalpha7 Activation and COVID-19.
Rieder AS; Wyse ATS
Mol Neurobiol; 2024 Feb; 61(2):581-592. PubMed ID: 37640915
[TBL] [Abstract][Full Text] [Related]
16. The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation.
Wang J; Kaplan N; Wysocki J; Yang W; Lu K; Peng H; Batlle D; Lavker RM
FASEB J; 2020 Aug; 34(8):10505-10515. PubMed ID: 32725927
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.
Youn JY; Zhang Y; Wu Y; Cannesson M; Cai H
Redox Biol; 2021 Oct; 46():102099. PubMed ID: 34509916
[TBL] [Abstract][Full Text] [Related]
18. Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis.
Albini A; Calabrone L; Carlini V; Benedetto N; Lombardo M; Bruno A; Noonan DM
Front Immunol; 2021; 12():718136. PubMed ID: 34646263
[TBL] [Abstract][Full Text] [Related]
19. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
